Collaboration aims to improve trial planning and expand patient access to biomarker-matched studies in AustraliaHighlights Collaboration aims to accelerate precision...
Clinical development of ARD-101 for hyperphagia in Prader-Willi Syndrome (PWS) may resume Aardvark will host a webcast to review available...
Annualized eGFR slope of -0.6 vs. -5.7 mL/min/1.73 m²/year for placebo, a 5.1 mL/min/1.73 m²/year treatment difference (p 89% and...
SALT LAKE CITY, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company...
JUPITER, Fla., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its annual Investor Day...
BEDFORD, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early...
WATERTOWN, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new...
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that it will...
LONDON, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a...
Nonprofit highlights winners and launches its popular Build Your Own Adventure Van fundraiser to advance research for childhood blindnessGILBERT, Ariz.,...
The FSR-GSCA unites 55 leading clinics worldwide in a powerful, shared commitment to advancing research, transforming patient care, and accelerating...
Not all supplements are created equal; No. 1 omega-3 brand‡ sets the bar for standards on purity, potency, freshness, and...
Integrated workflow of IQ-Meter, IQ-SurgiView and IQ-Flow demonstrated live for the first time; surgeons single out robotic visualization, console-free ECP...
New late-breaking data presented today at ASN Kidney Week 2026 QUELIMMUNE (SCD-PED) treatment group demonstrates statistically significant higher survival in...
Six of 12 evaluable participants receiving WAL0921 treatment experienced proteinuria (UACR) reduction greater than 20 percent; median 32.4 percent UACR...
Data from pre-clinical renal disease models demonstrate potential of izicopan for kidney protectionStructural modeling provides new insight into izicopan’s differentiated...
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 22 October 2026 – 6 PM CET Disclosure of a transparency notification from Aberdeen...
Met predefined primary and secondary objectives for the interim analysis CPV-104 was generally well tolerated in healthy volunteers and patients...
Revenue at 30 September 2026 Business in line with Group expectations Revenue at 30 September 2026 of €573.8m, down 1.3%...
New plan strengthens Alignment’s Arizona portfolio available to nearly 1.1 million Medicare beneficiaries across Maricopa, Pima and Santa Cruz countiesPHOENIX,...